NCT Number: NCT00046241
Prevention of Seasonal Affective Disorder
This is a placebo controlled study evaluating the effectiveness of medication in preventing depressive episodes in subjects with a history of Seasonal Affective Disorder (SAD).
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
GSK Clinical Trials Call Center, Calgary, Alberta, Canada
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.
Exclusion criteria
- Patient has a current or past history of seizure disorder or brain injury.
- Patient has a history or current diagnosis of anorexia nervosa or bulimia.
- Patient has recurrent summer depression more frequently than winter depression.
- Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
- Patient has initiated psychotherapy within the last 3 months.
Treatment and study plan
Primary outcomes
-
Time between randomization and onset of a seasonal depressive episode. Proportion of depression-free subjects.
Secondary outcomes
-
Change in HAMD-24 and -17 total score. Change in pain score.
Sponsors and collaborators
Lead sponsor
GlaxoSmithKline
Industry
Registry information
Official study title
A 7 Month, Multicenter, Randomized, Double-blind, Placebo-controlled Comparison of 150-300mg/Day of Extended-release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Affective Disorder in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up Phase
Important dates
- Study start
- 2002
- Primary completion
- 2003
- Study completion
- 2003
- First posted
- Sep 25, 2002
- Registry last updated
- Jan 23, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Optimizing Long-Term Outcomes for Winter Depression With CBT-SAD and Light Therapy
NCT03691792
Depressive Disorder, Mental Disorders
Burlington, Vermont, United States
View Trial DetailsInvestigation of Seasonal Variations of Brain Structure and Connectivity in SAD
NCT03313674
Depressive Disorder, Depressive Disorder, Major
Toronto, Ontario, Canada
View Trial DetailsInfrared Photomodulation Therapy for Seasonal Affective Disorder
NCT04251000
Depressive Disorder, Mental Disorders
New York, United States
View Trial DetailsSeasonal Affective Disorder and Visual Impairment
NCT03403959
Depressive Disorder, Eye Diseases
Copenhagen Ø, Denmark
View Trial Details